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Endothelin stimulates vascular hydroxyl radical formation:
Effect of obesity
Abstract
Reactive oxygen species (ROS) and endothelin-1 (ET-1) contribute to vascular pathophysiology in
obesity. In this context, whether ET-1 modulates hydroxyl radical (*OH) formation and the function of
ROS/*OH in obesity is not known. In the present study, formation and function of ROS, including *OH,
were investigated in the aorta of lean and leptin-deficient obese ob/ob mice. Hydroxyl radical formation
was detected ex vivo using terephthalic acid in intact aortic rings and the involvement of ROS in
ET-1-mediated vasoreactivity was analyzed using the antioxidant EPC-K1, a combination of
alpha-tocopherol and ascorbic acid. Generation of either *OH, *O(2)(-), and H(2)O(2) was strongly
inhibited by EPC-K1 (all P < 0.05). In obese mice, basal vascular *OH formation and ROS activity were
reduced by 3-fold and 5-fold, respectively (P < 0.05 vs. lean). ET-1 markedly enhanced *OH formation
in lean (6-fold, P < 0.05 vs. untreated) but not in obese mice. Obesity increased ET-1-induced
contractions (P < 0.05 vs. lean), and ROS scavenging further enhanced the response (P < 0.05 vs.
untreated). Exogenous ROS, including *OH caused stronger vasodilation in obese animals (P < 0.05 vs.
lean), whereas endothelium-dependent relaxation was similar between lean and obese animals. In
conclusion, we present a sensitive method allowing ex vivo measurement of vascular *OH generation
and provide evidence that ET-1 regulates vascular *OH formation. The data indicate that in obesity,
vascular formation of ROS, including *OH is lower, whereas the sensitivity to ROS is increased,
suggesting a novel and important role of ROS, including *OH in the regulation of vascular tone in
disease status associated with increased body weight.
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Mundy AL, Haas E, Bhattacharya I, Widmer CC, Kretz M,
Baumann K, Barton M. Endothelin stimulates vascular hydroxyl
radical formation: effect of obesity. Am J Physiol Regul Integr Comp
Physiol 293: R2218–R2224, 2007. First published September 26,
2007; doi:10.1152/ajpregu.00295.2007.—Reactive oxygen species
(ROS) and endothelin-1 (ET-1) contribute to vascular pathophysiol-
ogy in obesity. In this context, whether ET-1 modulates hydroxyl
radical (•OH) formation and the function of ROS/•OH in obesity is not
known. In the present study, formation and function of ROS, includ-
ing •OH, were investigated in the aorta of lean and leptin-deficient
obese ob/ob mice. Hydroxyl radical formation was detected ex vivo
using terephthalic acid in intact aortic rings and the involvement of
ROS in ET-1-mediated vasoreactivity was analyzed using the antiox-
idant EPC-K1, a combination of -tocopherol and ascorbic acid.
Generation of either •OH, •O2, and H2O2 was strongly inhibited by
EPC-K1 (all P  0.05). In obese mice, basal vascular •OH formation
and ROS activity were reduced by 3-fold and 5-fold, respectively
(P  0.05 vs. lean). ET-1 markedly enhanced •OH formation in lean
(6-fold, P  0.05 vs. untreated) but not in obese mice. Obesity
increased ET-1-induced contractions (P  0.05 vs. lean), and ROS
scavenging further enhanced the response (P  0.05 vs. untreated).
Exogenous ROS, including •OH caused stronger vasodilation in obese
animals (P  0.05 vs. lean), whereas endothelium-dependent relax-
ation was similar between lean and obese animals. In conclusion, we
present a sensitive method allowing ex vivo measurement of vascular
•OH generation and provide evidence that ET-1 regulates vascular
•OH formation. The data indicate that in obesity, vascular formation
of ROS, including •OH is lower, whereas the sensitivity to ROS is
increased, suggesting a novel and important role of ROS, including
•OH in the regulation of vascular tone in disease status associated with
increased body weight.
oxidative stress; acetylcholine; vasoconstriction; murine; ob/ob;
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ENDOTHELIN-1 ( ET-1) IS A POTENT vasoconstrictor (57) and mito-
gen (30) that has also been implicated in the pathogenesis of
metabolic diseases, including obesity and diabetes (4, 29, 31,
43). Endogenous ET-1 contributes to increased basal vascular
tone in human obesity (8, 31), and we and others have shown
that vascular responsiveness to ET-1 is enhanced in obesity (8,
50). Recent evidence also suggests that ET-1 stimulates the
generation of certain reactive oxygen species (ROS) (26, 52).
ROS are short-lived, oxygen intermediates that participate in
activation of intracellular signaling pathways (48) and regulate
cell function (14), and they are known to contribute to abnor-
mal vascular reactivity in obesity-related diseases such as
diabetes, atherosclerosis, and hypertension (16, 41, 44, 46, 48,
55). Although vascular effects of ROS have been often re-
garded as deleterious, resulting in impaired vasodilation and/or
enhanced vasoconstriction (45), ROS also have beneficial ef-
fects; indeed, superoxide (•O2), hydrogen peroxide (H2O2),
and the hydroxyl radical (•OH) may also act as vasodilators
under certain conditions (40, 53).
Previous studies have investigated vascular interactions
between ET-1 and •O2 or H2O2 (26, 52); however, little is
known about whether ET-1 also interacts with •OH, a highly
reactive ROS (33). Hydroxyl radical is mainly formed by
H2O2 via either the Fenton (13) or the Haber-Weiss reaction
(23):
Fe2  H2O2 3 Fe3  •OH  OH (Fenton Reaction)
H2O2  •O2 3Cu
2
•OH  OH  O2 (Haber-Weiss Reaction)
At high concentrations, hydroxyl radicals can cause mem-
brane damage, DNA and RNA fragmentation, and lipid per-
oxidation (9, 49). In the vasculature, •OH regulates vasocon-
striction (49) and vasodilation (40) under normal and patho-
logical conditions (39, 40).
The aim of the present study was to characterize the inter-
actions between ET-1 and ROS/•OH in the vasculature of
normal C57BL6/J laboratory mice and to determine the possi-
ble modulatory effects of obesity on ROS-mediated vascular
tone and •OH production using a model of leptin-deficient
obesity.
METHODS
Animals
Healthy 40-wk-old male C57BL/6 mice (controls) and severely
obese leptin-deficient mice (B6.V-Lepob/J; Charles River, Sulzfeld
Germany; obese) were used. Body weight of obese mice was 58 4 g
compared with 29  1 g for control mice. Animals were held at the
institutional animal facilities and received standard rodent chow and
tap water ad libitum. Housing facilities and experimental protocols
were approved by the local authorities for animal research (Kommis-
sion fu¨r Tierversuche des Kantons Zu¨rich, Switzerland) and conform
to the Guide for the Care and Use of Laboratory Animals published
by the U.S. National Institutes of Health (NIH Publication No. 85-23,
revised 1996). Mice were anesthetized (xylazine: 100 mg/kg body wt;
ketamine: 23 mg/kg body wt; and acepromazine: 3.0 mg/kg body wt
ip), and exsanguinated via cardiac puncture.
Measurement of Vascular Hydroxyl Radical Formation
To quantify •OH generation in very small specimens of living
vascular tissue ex vivo, we established a method using terephthalic
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acid (TPA), a specific probe for •OH detection, slightly modified from
published in vitro protocols (3, 42). Hydroxylation of TPA yields a
stable and highly specific isomer (2-hydroxyl terephthalic acid, TPA-
OH) (42) that is not formed by reaction with either superoxide or
hydroperoxides (3). The sensitivity and specificity of TPA to detect
•OH are comparable to that of the spin trap 5,5 dimethyl-1-pyrroline
N-oxide (27), as detected by electron spin resonance technique (see
also supplemental information, which may be found online at the
American Journal of Physiology—Regulatory, Integrative and Com-
parative Physiology website). Vascular •OH generation was measured
in aortic rings, which were left unconstricted and placed in gassed
Krebs solution (95% O2, 5% CO2, 37°C, pH 7.4) for 4 h containing
2.5 mM TPA in the absence (basal •OH formation) or in the presence
of 106 mol/l ET-1 (ET-1-stimulated •OH formation). TPA-OH was
quantified fluorometrically (excitation: 326 nm, emission: 432 nm)
using a microplate reader (SpectraMax M2) (42). Hydroxyl radical
formation was calculated as relative light units per milligram of
protein after subtraction of background fluorescence. Protein was
extracted from vascular tissue in a RIPA buffer containing orthovana-
date, PMSF, and complete mini protease inhibitor (Roche, Rotkreuz,
Switzerland) using a cell shredder (Qiagen, Hombrechtikon, Switzer-
land) and incubated for 30 min at 4°C. Insoluble material was
separated by centrifugation and protein content of the soluble fraction
was quantified using Bio-Rad Protein Assay solution (Bio-Rad, Re-
inach, Switzerland), according to the manufacturer’s instructions.
Characterization of the Antioxidant Activities of EPC-K1
The effects of EPC-K1 on •O2 and •OH formation and on the
stability of H2O2 were determined using specific assays (12). The
radical scavenger EPC-K1, a water-soluble compound, is a combina-
tion of two known antioxidants, vitamin E (alpha-tocopherol) and
vitamin C (ascorbic acid) (54) linked by a phosphate diester (See also
supplemental information that is available online at the American
Journal Physiology—Regulatory, Integrative and Comparative Phys-
iology website.). Effects of EPC-K1 (101 mg/ml) on xanthine/
xanthine oxidase-mediated •O2 generation were determined by
L-012-dependent chemiluminescence, as described (10). The overall
measuring time was 6 min, and a total of 24 measurements were taken
during this period. Each measurement was for 10 s, and the interval
between each reading was 5 s (Lumat LB 9507, Berthold Technolo-
gies, Regensdorf, Switzerland). Total superoxide anion formation was
determined by cumulative measurements of chemiluminescence over
6 min and calculated after subtracting the background. Hydroxyl
radical was generated from the reaction of Fe2 and ascorbic acid (51)
(both at 100 mol/l) in warm, gassed Krebs solution (37°C, 95% O2,
5% CO2), in the presence or absence of EPC-K1 (101 mg/ml) (35),
and quantified using TPA (2.5 mM) hydroxylation (42). The effect of
EPC-K1 (101 mg/ml) on hydrogen peroxide (0.3 mol/l H2O2) was
assessed using the Amplex Red assay (Molecular Probes, Eugene,
OR), as previously described (18). The reaction product resorufin (18)
was detected fluorometrically (excitation and emission wavelengths:
571 nm and 585 nm, respectively) using a SpectraMax M2 (see also
supplemental information online at the American Journal of Physiol-
ogy—Regulatory, Integrative and Comparative Physiology website).
Vascular Function Studies
The aorta was excised and placed in cold (4°C) Krebs-Ringer
bicarbonate solution [in mmol/l: NaCl 118.6; KCl 4.7; CaCl2 2.5;
MgSO4 1.2; KH2PO4 1.2; NaHCO3 25.1; ethylenediaminetetraacetic
acid calcium disodium salt (EDTANa2Ca) 0.026; glucose 10.1], dis-
sected free of connective tissue under a microscope (Olympus SZX9,
Volketswil, Switzerland), and cut into rings 3 mm in length. Special
care was taken not to damage the endothelium during this procedure.
Segments of thoracic aorta were mounted onto tungsten wires (100
m in diameter) and transferred to water-jacketed organ baths con-
taining Krebs solution (95% O2,-5% CO2 at 37°C, pH 7.4) and
connected to force transducers (Hugo Sachs Elektronik, March-Hug-
stetten, Germany) (50). Resting tension was gradually increased to the
optimal level as previously described (50); vessels were repeatedly
exposed to 100 mM KCl until a stable contraction response was
achieved.
Endothelium-dependent and -independent vascular function. Endo-
thelium-dependent relaxation to ACh (0.1–10 mol/l) was determined
in the presence of indomethacin (10 mol/l, a nonselective cycloox-
ygenase inhibitor, 30 min preincubation) in rings preconstricted with
phenylephrine to 80% of KCl-induced contraction, as previously
described (5). Endothelium-independent vasodilation was investi-
gated using the nitric oxide (NO) donor sodium nitroprusside (10
mol/l).
Reactive oxygen species and basal vascular tone. Rings were
pretreated with L-nitro-arginine methyl ester (L-NAME, 300 mol/l)
for 15 min to block effects of endogenous NO (24). To determine
whether endogenous ROS formation contributes to basal vascular
tone, the ROS scavenger EPC-K1 (101 mg/ml equal to 141.46 M)
(35) was applied to quiescent vascular rings and the resultant con-
traction, reflecting basal vascular ROS generation (6, 20) was mea-
sured. The contractile responses of quiescent vessels to scavengers or
enzyme inhibitors allow us to indirectly quantify basal generation of
molecules such as NO or •O2 in a particular vascular bed (6, 20).
Vascular responses to ET-1. Vascular rings were exposed to ET-1
(0.01–300 nmol/l) in the presence of L-NAME (300 mol/l) for 30
min, as described (56). To investigate the role of ROS for ET-1-
induced contraction, selected rings were also preincubated with the
ROS scavenger EPC-K1 (101 mg/ml) for 15 min.
Effects of ROS on vascular tone. Vascular responses to exog-
enously generated ROS/•OH generated by the reaction between Fe2
and ascorbic acid (51) were investigated in aortic rings preconstricted
with phenylephrine, as previously described (36).
Gene Expression Measurements
Steady-state mRNA expression levels of vascular nitric oxide
synthase (NOS) isoforms 2 and 3 were determined by real-time
quantitative reverse transcriptase-PCR. Aortic total RNA was ex-
tracted using the RNeasy micro kit for RNA isolation from fibrous
tissues (Qiagen, Hilden, Germany). Purity of RNA was controlled by
RT() reactions (PCR with nontranscribed RNA). RNA was reverse-
transcribed with the Omniscript RT kit (Qiagen, Hilden, Germany).
Real-time quantitative PCR was used to determine relative expres-
sion levels of murine genes encoding for NOS2 (Nos2, locus:
NM_010927), NOS3 (Nos3, locus: NM_008713) and the housekeep-
ing gene tyrosine-3-monooxygenase (locus: NM_011740). For ampli-
fication of a tyrosine-3-monooxygenase-specific cDNA fragment 5-
CGA GCA GGC AGA GCG ATA TG-3 was used as the forward and
5-AGA CGA CCC TCC ACG ATG AC-3 as the reverse primer, for
a Nos2-specific fragment 5-GCA CCG AGA TTG GAG TTC-3 as
the forward and 5-AGC ACA GCC ACA TTG ATC-3 as the reverse
primer. 5-CCT AGT CCT CGC CTC CTTC-3 was used as the
forward primer for a Nos3-specific fragment and 5-ACC ACT TCC
ATT CTT CGT AGC-3 as the reverse primer. Two-step PCR was
performed with iQ SYBR Supermix PCR kit (Bio-Rad) as follows:
activation of the hot start Taq polymerase for 3 min (95°C), followed
by 40 cycles of denaturation at 95°C for 15 s (step 1), and annealing
and extension at 60°C for 1 min (step 2). Fluorescence was detected
at the end of each extension step. Identity and specificity of amplicons
were confirmed by agarose gel electrophoresis, melting curve analy-
sis, and sequencing (Microsynth, Balgach, Switzerland). Steady-state
mRNA expression levels were calculated by normalizing the relative
amount of each mRNA to the housekeeping gene tyrosine-3-mono-
oxygenase (28) and expressed as arbitrary units (AU).
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Materials
ET-1 and L-NAME were from Alexis Corp (Lausanne, Switzer-
land). EPC-K1 was from Senju Pharmaceuticals (Osaka, Japan).
L-012 was from Wako Chemicals (Neuss, Germany), and Amplex
Red was from Molecular Probes (Eugene, OR). All other chemicals
were from Sigma Chemicals (Buchs, Switzerland).
Statistical Analyses
Data are given as means  SE, and n denotes the number of
animals used per experiment. Contraction is expressed as a percentage
of 100 mM KCl-induced contraction, and dilations are given as a
percentage of the maximal contraction. EC50 values (as negative
logarithm pD2) were calculated by nonlinear regression analysis, and
area under the curve was calculated for each individual curve using
SigmaPlot (SPSS Chicago, IL). Data were analyzed using ANOVA
for repeated measurements with Bonferroni correction, the Mann-
Whitney U-test, or unpaired Student’s t-test when appropriate. A P
value 0.05 was considered significant.
RESULTS
Efficacy of •OH-Generating Systems in Krebs Solution
Hydroxyl radical generation was determined in vitro by
TPA, a specific probe for •OH (27). The efficacy of •OH
generated by ascorbic acid and Fe2 was compared with
another •OH-generating system consisting of H2O2 and Fe2.
The amount of •OH generated by vitamin C and Fe2 was
2.6-fold higher compared with H2O2 and Fe2 (P  0.05 vs.
H2O2 and Fe2, Table 1). DMSO, a known •OH scavenger (1),
blocked in either system •OH formation by80%, as shown in
Table 1 (See also supplemental data for this article, which is
available online at the American Journal of Physiology—
Regulatory, Integrative and Comparative Physiology web-
site.).
Vascular Hydroxyl Radical Formation and Acute Effects
of ET-1
TPA was used to quantify vascular •OH formation ex vivo.
Formation of •OH was detected under basal conditions in
uncontracted aortic rings from control mice [2.5  0.1 relative
fluorescence units (RFU)/mg protein, Fig. 1A] and markedly
increased by endothelin-1 (15.0  1.0 RFU/mg protein, six-
fold, P  0.0001, vs. untreated, Fig. 1B). Basal •OH formation
was reduced approximately threefold in obese animals (P 
0.0001 vs. lean, Fig. 1, A and B) and ET-1 slightly increased
this attenuated •OH formation (0.6 0.1 to 2.3 0.3 RFU/mg
protein, P  0.0001 vs. untreated, Fig. 1B). Interestingly,
ET-1-stimulated •OH formation in obese mice was still below
basal levels of •OH detected in lean mice (2.3  0.3 vs. 2.5 
0.1 RFU/mg protein, respectively).
Effects of EPC-K1 on ROS Formation and Vascular Tone
The effects of EPC-K1 on in vitro generation of •O2, •OH,
and H2O2 were determined. EPC-K1 inhibited xanthine-oxi-
dase-mediated •O2 generation by 74  2% (P  0.0001 vs.
control), that of ascorbic acid and Fe2-mediated •OH forma-
tion by 84 1% (P 0.0001 vs. control), and that of H2O2 by
61  2% (P  0.0001 vs. control). We next investigated basal
ROS bioactivity in quiescent aortic rings by measuring changes
in vascular tone after applying EPC-K1, which caused contrac-
tion in all rings investigated (P  0.05, vs. untreated, Fig. 2).
EPC-K1-induced contractions were markedly reduced in obese
mice (5-fold, P  0.05, vs. control).
Effects of Exogenous ROS on Vascular Tone
The addition of exogenous ROS/•OH to precontracted vas-
cular rings caused a vasodilator response (P  0.0001, vs.
untreated, Fig. 3, ROS/•OH in Fig. 3A), that was enhanced
threefold by obesity (P  0.05 vs. control).
Function and Expression of Vascular NO Synthases
NO-mediated endothelium-dependent relaxation to ACh
was similar in lean and obese mice [94  1.6 vs. 94 
Table 1. Efficacy of in vitro •OH-generating systems
•OH-Generating System DMSO TPA-OH, relative fluorescence units
Control  0
Control  0
H2O2  Fe2  69139*‡
H2O2  Fe2  10215*
Vitamin C  Fe2  1804197*†‡
Vitamin C  Fe2  38813*
The amount of •OH-generated by vitamin C and Fe2 (100 M each) and
that by H2O2 and Fe2 was measured by the hydroxylation of terephthalic acid
(TPA-OH). The •OH-generating systems were investigated in Krebs solution
in the presence or absence of the •OH radical scavenger DMSO (3 mM). *P 
0.05 vs. control (Krebs buffer). †P  0.05 vs. H2O2 and Fe2. ‡P  0.05 vs.
•OH-generating systems in the presence of DMSO.
Fig. 1. Vascular •OH formation in lean control
(open bars) and obese ob/ob mice (solid bars), as
measured by TPA hydroxylation. Under unstimu-
lated conditions basal formation of •OH was de-
tected. Obesity reduced basal •OH formation by
three-fold (P  0.001 vs. lean). Exposure to en-
dothelin-1 (ET-1) (106 mol/l) increased •OH
formation in lean control mice but had only a
small effect in obese mice. Values are expressed
as fluorescence units per milligram protein; n 	
6/group *P  0.001 vs. basal; †P  0.001 vs.
lean.
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3.3%, not significant (ns), Fig. 3B], as was relaxation to sodium
nitroprusside (SNP) (109  1.3 vs. 107  1.5%). Simi-
larly, vascular expression of NOS3 mRNA was similar be-
tween control (504  53 AU) and obese mice (471  74 AU,
ns), as were NOS2 mRNA levels (control, 1.2  1 AU, n 	 4;
obese, 0.95  0.35 AU, n 	 7, ns).
Effect of Endogenous ROS on ET-1-Induced Contractility
Contractions to ET-1 were enhanced by obesity (20.4  4.9%
vs. 10.6 1.5%, P 0.05, Fig. 4, A and B and Table 2). In obese
mice, scavenging of ROS by EPC-K1 further enhanced ET-1-
induced vasoconstriction (45  9%, P  0.05 vs. untreated);
this effect was absent in lean controls (Fig. 4).
DISCUSSION
This study demonstrates interactions between the vasocon-
strictor ET-1 and ROS/•OH under normal conditions and in
obesity. We present a sensitive method to quantify hydroxyl
radical formation in small vascular specimens ex vivo, using
TPA hydroxylation, and show that ET-1 acutely stimulates
vascular •OH formation in the aorta of normal laboratory mice.
The results provide evidence that basal ROS activity, as well as
ET-1-stimulated •OH formation were markedly reduced in
obesity. Scavenging of endogenous ROS with the nonselective
radical scavenger EPC-K1 increased vasoconstrictor responses
to ET-1 in aortic rings of obese animals, but not in controls,
indicating that ROS antagonize ET-1-mediated vasoconstrictor
responses in obesity.
•OH is a highly reactive ROS, and its role in pathophysiol-
ogy has only been clarified in part (17, 25, 48). Investigations
on the role of •OH in the pathophysiology of cardiovascular
disorders have, to date, been hindered by the lack of sensitive
and specific methods. Previously, salicylic acid has been used
to detect •OH formation (11). However, because salicylic acid
also detects peroxynitrite (19) and inhibits enzymes involved in
ROS production (7, 21), salicylic acid cannot be considered a
specific probe for •OH. Therefore, one of the goals of the
present study was to establish a specific and sensitive method
that would allow us to measure •OH generation in small
vascular specimens ex vivo. We used TPA, which is a highly
specific and sensitive probe for •OH (3), as shown by electron
spin resonance experiments (27) (see also supplemental infor-
mation online at the American Journal of Physiology—Regu-
latory, Integrative and Comparative Physiology website), and
therefore, no other probes for •OH were used in our experi-
ments. Using the TPA-based •OH detection method, the
present study shows that basal •OH formation can indeed be
Fig. 2. Basal reactive oxygen species (ROS) formation in quiescent aortic
rings expressed as a change in basal vascular tone in response to the ROS
scavenger EPC-K1. Inhibition of basal ROS resulted in contraction in all
vessels studied. In obesity, basal ROS formation was markedly reduced
(fivefold, P  0.05). Contractions to EPC-K1 are expressed as a percentage of
KCl-induced contractions. n 	 5–14/group. *P  0.05 vs. lean.
Fig. 3. Dilator responses to exogenous ROS/•OH (A) and endothelium-depen-
dent relaxation to ACh (B) in aortic rings of lean and obese animals precon-
tracted with phenylephrine. Dilations to ROS/•OH are expressed as a percent-
age of precontraction. n 	 5–14/group. *P  0.05 vs. lean. Relaxation to ACh
is expressed as percent of precontraction. n 	 7–9/group.
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detected in very small specimens of arterial tissue in both lean
and obese animals.
Endothelin contributes to the pathogenesis of atherosclero-
sis, hypertension, and diabetes (30, 43) and has been previ-
ously shown to stimulate the generation of ROS such as •O2
and H2O2 (26, 52). Presently, there is no information on
whether ET-1 modulates vascular formation of •OH. Using
TPA as a probe for •OH, we found that ET-1 is a potent
stimulus of vascular •OH formation in animals with normal
body weight. An unexpected finding of the present study was
that this stimulating effect of ET-1 was more or less abrogated
in obese mice. Because of the limitations in tissue and animals,
only a single concentration of •OH was used. To our knowl-
edge, this is not only the first demonstration that ET-1 modu-
lates vascular •OH formation, but also that both basal and
stimulated •OH formation are markedly reduced in obesity. In
line with these results, basal vascular activity of ROS, as
measured indirectly by EPC-K1-induced contractions, was also
reduced in obese animals. Our study did not identify the nature
of ROS mediating the observed effects in response to EPC-K1.
One of the potential candidates of ROS could be •O2 as in a
most recent study using young obese db/db mice, which
express a mutated leptin receptor and unlike the ob/ob animals
used in our study show high circulating leptin levels, Grien-
dling and colleagues (41) demonstrated that aortic membrane
superoxide generation was enhanced compared with lean con-
trols.
EPC-K1 has been previously proposed to be a scavenger that
is selective for •OH (35). On the basis of its chemical structure
that combines ascorbic acid and -tocopherol linked by a
phosphodiester, it is very unlikely to be specific for •OH
scavenging (54). Indeed, our results now show that EPC-K1
not only scavenges •OH but also that it potently inactivates
•O2 and H2O2. Therefore, in the experiments involving EPC-
K1, scavenging of any of the ROS mentioned may contribute
to the observed changes in vasoreactivity. According to a
previous report, EPC-K1 as a ROS scavenger induces NO-
independent relaxation in precontracted canine coronary arter-
ies (47). In the present study, however, we demonstrate that
EPC-K1 also causes contraction of quiescent murine aortic
rings, reflecting basal ROS vasodilator bioactivity. These dif-
ferences in the effects of EPC-K1 are likely to be explained by
1) the state of contraction of the vascular rings, 2) by the type
of artery studied and/or 3) by interspecies differences.
To investigate the effects of exogenous ROS/•OH on vas-
cular tone, we used ascorbic acid and iron (45, 49) as a
ROS/•OH generating system. In vitro experiments confirmed
that this system is indeed a strong inductor of •OH formation
and that concentration-dependent relaxation can be achieved
(see supplemental information for details). The results of the
present study demonstrate that exogenous ROS/•OH cause
vasodilation, an effect that is markedly enhanced by obesity.
This suggests that obesity modulates the sensitivity of the
vasculature to vasodilator activities of ROS. Also, it is likely
that obesity per se and not leptin deficiency enhances the
responsiveness to ROS/•OH, since enhanced vascular relax-
ation to ROS/•OH was also observed in a model of diet-
induced obesity (36). An unexpected finding was that no
differences in the NO-mediated endothelium-dependent relax-
ation in the presence of cyclooxygenase inhibitors were seen
between obese and lean animals. The steady-state mRNA
expression levels of endothelial nitric oxide synthase (eNOS/
NOS3) was also similar between the groups. Of note, in these
experiments, a cyclooxygenase inhibitor was used since obe-
sity enhances cyclooxygenase-mediated production of vaso-
constrictor prostanoids (36, 50), which attenuate endothelium-
dependent vascular relaxation in response to ACh in obesity
(50). In a recent study, endothelium-dependent relaxation was
Fig. 4. Contractions to ET-1 (0.01–300 nmol/l) in the
presence of L-NAME in aorta of lean (open symbols)
and obese mice (solid symbols) in untreated rings (left),
and after preincubation with EPC-K1 (right). Obesity
was associated with increased contractions to ET-1, and
ROS scavenging increased contractions to ET-1 in
obese animals only. Data are expressed as a percentage
of contraction to 100 mM KCl; n	 8–19 /group. *P
0.05 vs. lean. †P  0.05 vs. untreated.
Table 2. pD2 values and values of area under the ET-1
concentration-response curve (AUC)
Lean Obese
Untreated EPC-K1 Untreated EPC-K1
pD2 8.50.1 9.20.3† 8.50.1 9.20.3†
AUC 213 142 4210* 13739†‡
pD2 values and values of area under the endothelin-1 (ET-1) concentration-
response curve (area under the curve, AUC) were calculated for each concen-
tation-response curve, and data were averaged. In untreated rings of control
and obese mice, pD2 values were similar. EPC-K1 increased AUC threefold
only in the aorta of obese animals. *P  0.05, lean vs. obese. †P  0.05 vs.
untreated. ‡P  0.05 vs. lean, EPC-K1.
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found to be impaired in the aorta of obese db/db mice (41),
which is likely to be explained by the lack of a cyclooxygenase
inhibitor in the organ chamber experiments (50). The results of
the present study are in line with previous studies showing that
in the presence of cyclooxygenase inhibition, NO-dependent
relaxation actually remains unaffected in diet-induced, as well
as in monogenetic forms of obesity in rodents (2, 22, 36).
Similar to our recent study using a model of diet-induced
obesity (50), we found that contractions to ET-1 are also
increased in obesity due to leptin deficiency. The role of ROS
for ET-1-induced contractions was investigated using the ROS
scavenger EPC-K1. While in lean animals, EPC-K1 had no
effect on contractions to ET-1, the antioxidant markedly en-
hanced contractions in obese animals, suggesting that endog-
enous ROS antagonize ET-1-mediated vasoconstriction in obe-
sity, but not under normal conditions. The present data also
suggest that this indirect vasodilator activity of ROS in obesity
is independent of NO, since all experiments were performed in
the presence of a NO synthase inhibitor. Indeed, reactive
oxygen species have been shown to block vasoconstriction and
mediate vasorelaxant effects in the vasculature by 1) activation
of endothelium-dependent hyperpolarizing factor (32, 37), 2)
by activating cGMP pathway (15, 34), and/or 3) by inhibition
of phosphorylation of myosin light chain protein (38). In the
present study, because NOS was blocked, cyclic GMP is
unlikely to play a role in the ROS-mediated responses ob-
served. We would like to again emphasize that the findings of
ET-1-induced •OH generation and the observed changes in
vasoreactivity are two independent observations (tissue speci-
mens vs. arterial rings on passive tension), which were made
under different conditions. Therefore, ET-1-derived •OH gen-
eration is unlikely to be the sole mechanistic link for the
observed changes in vasoreactivity.
Perspective
The present study demonstrates novel vascular effects and
interactions between ET-1 and ROS/•OH under normal condi-
tions and in states of obesity, in particular. Furthermore, the
data presented here suggest possible “protective” vasodilator
activities of ROS/•OH, which are altered in obesity. The
possible pathophysiologicial significance of these observations
in human obesity and/or insulin resistance remains yet to be
shown. However, the activation of direct and indirect ROS-
mediated vasodilator mechanisms may explain the clinical
observation that only some, but not all, obese patients develop
hypertension.
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